利复星序贯疗法治疗获得性肺炎67例体会

杨巍巍

您当前的位置：

首页 >

文章列表页 >

利复星序贯疗法治疗获得性肺炎67例体会

更新时间：2021-08-23

- 利复星序贯疗法治疗获得性肺炎67例体会
- The Effectiveness of the Sequential Therapy by Levofloxacin Tosilate in Treating Community Acquired Pneumonia
- 高校保健医学研究与实践 2006年第2期页码：31-32
- 作者机构：
  
  清华大学医院,北京,100084
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R563.1
- 纸质出版日期：2006，
扫描看全文
[1]杨巍巍.利复星序贯疗法治疗获得性肺炎67例体会[J].高校保健医学研究与实践,2006(02):31-32.

YANG Wei-wei. The Effectiveness of the Sequential Therapy by Levofloxacin Tosilate in Treating Community Acquired Pneumonia[J]. Health Medicine Research and Practice, 2006,(2):31-32.
[1]杨巍巍.利复星序贯疗法治疗获得性肺炎67例体会[J].高校保健医学研究与实践,2006(02):31-32. DOI：

YANG Wei-wei. The Effectiveness of the Sequential Therapy by Levofloxacin Tosilate in Treating Community Acquired Pneumonia[J]. Health Medicine Research and Practice, 2006,(2):31-32. DOI：

摘要

目的评价利复星序贯治疗社区获得性肺炎的疗效

以期指导临床工作。方法对67例社区获得性肺炎患者

静脉滴注利复星每次0.2g

每日2次

症状明显改善后口服。结果临床有效率95.6%

细菌清除率90.9%

药物不良反应发生率4.5%。结论利复星序贯治疗社区获得性肺炎安全有效

值得临床推广。

Abstract

Objective To evaluate the effectiveness of the sequential therapy by using Levofloxacin Tosilate in treating community acquired pneumonia. Method All of 67 community acquired pneumonia patients were treated by the method of intravenous drip of Levofloxacin Tosilate 200mg/d bid. They took the same medicine orally after their symptom was improved obviously.Results The total clinical effective rate was 95.5 %

and bacteria eliminating rate was 90.9 %

and the rate of adverse reaction on the drug was 4.4 %. Conclusion Levofloxacin Tosilate is an effective and safe antibacterial drug in treating community acquired pneumonia sequentially.

关键词

利复星社区获得性肺炎序贯疗法疗效

Keywords

levofloxacin tosilatecommunity acquired pneumoniasequential therapyeffectiveness

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

社区获得性肺炎95例临床特征分析